HER2 EXPRESSION
Clinical trials for HER2 EXPRESSION explained in plain language.
Never miss a new study
Get alerted when new HER2 EXPRESSION trials appear
Sign up with your email to follow new studies for HER2 EXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets hard-to-treat cancers in early trial
Disease control Not yet recruitingThis study tests a drug called Trastuzumab Rezetecan in 15 adults with advanced solid tumors that have the HER2 protein. The goal is to see if the drug can shrink tumors. Participants get the drug by IV every 3 weeks. This is for people whose cancer has worsened after other treat…
Matched conditions: HER2 EXPRESSION
Phase: PHASE2 • Sponsor: Haihua Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New imaging study aims to unlock HER2 secrets in lung cancer
Knowledge-focused Not yet recruitingThis study uses a special PET scan to track a tracer called 89Zr-trastuzumab in people with advanced lung cancer that has HER2 changes. The goal is to see if the tracer builds up differently in tumors with HER2 mutations versus those with too much HER2 protein. About 20 adults wi…
Matched conditions: HER2 EXPRESSION
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC